Regulatory S16 Ep43: FDA Approval Insights: Rucaparib for BRCA Mutation-Associated mCRPC: With David Morris, MD, FACS; and Alan H. Bryce, MD OncLive PodcastWelcome to OncLive On Air !RegulatoryOncologyRead full story pharminent March 31, 2026 (Last updated: April 1, 2026) OncLive Podcast Welcome to OncLive On Air ! RegulatoryOncologyRead full story Post navigation Previous: Novo hits back at rivals with cut-price Wegovy subscriptionsNext: NHS to offer Wegovy to a million more people in England Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026